My passion is science and its potential for improving quality of life. My goal is to see quality therapeutics developed and marketed through strategic commercialization. To achieve this, I am always searching for opportunities to build relationships with thought leaders and professionals engaged in tackling important health concerns.

My greatest asset is experience encompassing the pre-approval stages of drug and device development, from basic research (DNAX and Duke), translational research (Duke), clinical research (Stanford and Quintiles), to commercialization (University of Miami, Novelios and Reveve Consulting). I understand what both small and large companies experience in assimil...